ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135758 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135758; 2) Community: the network communities that were significantly associated with the response to NSC 135758; 3) Molecule: the relationships between components within communities and NSC 135758; 4) MDR: the compounds that were significantly associated with the NSC 135758.

NSC Compound Enrichment Correlation
NSC 108165 CP 12252-1 0.00220234298765534 -0.034886656
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.00220234298765537 0.78740403
NSC 357704 Cyanomorpholinodoxorubicin 0.00220234298765537 0.67988063
NSC 606172 Camptothecin Derivative 0.00220234298765537 0.78776643
NSC 658103 Null 0.00220234298765537 0.65188395
NSC 663334 Null 0.00220234298765537 0.17996632
NSC 681636 Camptothecin Derivative 0.00220234298765537 0.79950155
NSC 687305 4-(N-acetyl-N-ethylamino)isoquinoline-1-carboxaldehyde thiosemicarbazone 0.00220234298765537 0.4859928
NSC 735037 Camptothecin Derivative 0.00220234298765537 0.82021414
NSC 740520 6-(3-Bromopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.00220234298765537 0.67168353
Total:49  Current:4    [First] [Prev] [Next] [Last]